Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Geert Meyfroidt and Matthias Engelen.
Geert Meyfroidt
Connection Strength
0.180
Matthias Engelen
  1. Early high antibody titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma. Eur Respir J. 2022 02; 59(2).
    View in: PubMed
    Score: 0.062
  2. Corrigendum to "itraconazole for COVID-19: Preclinical studies and a proof-of-concept randomized clinical trial Laurens". EBioMedicine. 2021 Jul; 69:103454.
    View in: PubMed
    Score: 0.060
  3. Itraconazole for COVID-19: preclinical studies and a proof-of-concept randomized clinical trial. EBioMedicine. 2021 Apr; 66:103288.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.